Presentation 3

Download as pptx, pdf, or txt
Download as pptx, pdf, or txt
You are on page 1of 15

VIGABATRIN

Vigabatrin
Vigabatrin

• Adjunctive treatment for infantile spasms and adult


refractory complex partial seizure
Vigabatrin Mechanism Vigabatrin

• Irreversible & competitive binding to GABA


transaminase.
Vigabatrin Mechanism Vigabatrin

• Possibly also might stimulate GABA release.

• Brain GABA increases by 40% at 2 hours post-


dose
Vigabatrin
Vigabatrin

• Linear dose relationship


• Reduces phenytoin level by 20%
• Dosage adjustment for decreased renal
clearance
Vigabatrin
Vigabatrin Dosing Complex Partial Seizures

• Adults: Initial: 500 mg twice daily; increase


daily dose by 500 mg at weekly intervals
based on response and tolerability.
Recommended dose: 3 g/day
• Children: Oral: Initial: 40 mg/kg/day divided
twice daily; maintenance dosages based on
patient weight
Vigabatrin Dosing Infantile Spasm Vigabatrin

• Initial dosing: 50 mg/kg/day divided twice


daily; may titrate upwards by 25-50
mg/kg/day every 3 days to a maximum of 150
mg/kg/day
Vigabatrin
Vigabatrin Effectively Treats Tuberous Sclerosis

Practice Parameter: Medical Treatment of


Infantile Spasms:
“Overall cessation of spasms was seen in 41 of
45 (91%) of children treated with vigabatrin,
with a 100% response rate seen in five
studies.”
Vigabatrin
Vigabatrin Visual Adverse Effects

• Bilateral irreversible concentric peripheral


field defects occur in 30-50% of cases
• Most with defects were treated for at least 6
months; often stable after 2 years
• Defects often asymptomatic but might impair
driving.
Vigabatrin
Vigabatrin Visual Adverse Effects

• Adults: visual testing done at baseline & each


6 months
• Infants: visual testing done at baseline & test
each 3 months for 18 months, then each 6
months (sedate for electroretinogram)
Vigabatrin
Vigabatrin Visual Effects

• Common approach is treatment for a duration


under 3 months; consider discontinuation
after 6 months, if seizures are effectively
controlled.
• An experimental animal study found that
taurine prevented the visual adverse effect
Vigabatrin
Vigabatrin White Matter Changes

• Lesions were asymptomatic & reversible


• Age: 9 months - 18 years (median 5.4 yrs)
• 8 of 23 (34%) subjects were affected
• Brain scans show lesions in basal ganglia,
thalamus, brainstem, & dentate nucleus.
Vigabatrin
Vigabatrin White Matter Changes
Vigabatrin
Vigabatrin Summary

Positive
• High effectiveness for infantile spasms
• Few significant drug interactions; exception is
phenytoin
• Infrequent need for serum drug levels
• Low protein binding

Negative
• Irreversible visual field defects due to peripheral
retinal atrophy.
• White matter lesions
• Behavioural changes
• Weight gain, amnesia
• High cost
Vigabatrin
Role of Vigabatrin

• Vigabatrin is likely to be among the last


choices for adjuvant treatment of simple and
complex partial seizures.
• Can also be used in generalised seizures.
• Vigabatrin is a good 1st choice for infantile
spasms from tuberous sclerosis (TS).

You might also like